EA200400734A1 - Способ и композиция для потенциирования действия опиатного анальгетика - Google Patents
Способ и композиция для потенциирования действия опиатного анальгетикаInfo
- Publication number
- EA200400734A1 EA200400734A1 EA200400734A EA200400734A EA200400734A1 EA 200400734 A1 EA200400734 A1 EA 200400734A1 EA 200400734 A EA200400734 A EA 200400734A EA 200400734 A EA200400734 A EA 200400734A EA 200400734 A1 EA200400734 A1 EA 200400734A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- composition
- opiative
- potentiating
- analgetic action
- treating pain
- Prior art date
Links
- 230000000202 analgesic effect Effects 0.000 title abstract 2
- 230000003389 potentiating effect Effects 0.000 title 1
- 229940127240 opiate Drugs 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 239000002308 endothelin receptor antagonist Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Addiction (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Zoology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Раскрываются композиция и способы лечения боли и подавления или реверсирования толерантности к опиатным анальгетикам. В композиции и способе используются опиатный анальгетик и антагонист эндотелина в качестве активных агентов для лечения боли у млекопитающих, включая людей.Отчет о международном поиске был опубликован 2003.09.25.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33359901P | 2001-11-27 | 2001-11-27 | |
PCT/US2002/037461 WO2003045434A2 (en) | 2001-11-27 | 2002-11-22 | Endothelin antagonists ina method and composition for potentiating an opiate analgesic |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200400734A1 true EA200400734A1 (ru) | 2004-12-30 |
Family
ID=23303472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200400734A EA200400734A1 (ru) | 2001-11-27 | 2002-11-22 | Способ и композиция для потенциирования действия опиатного анальгетика |
Country Status (14)
Country | Link |
---|---|
US (3) | US7973064B2 (ru) |
EP (1) | EP1448233A2 (ru) |
JP (1) | JP2005513033A (ru) |
CN (1) | CN1646166A (ru) |
AU (1) | AU2002348224A1 (ru) |
BR (1) | BR0214481A (ru) |
CA (1) | CA2464768C (ru) |
CO (1) | CO5590940A2 (ru) |
EA (1) | EA200400734A1 (ru) |
EC (1) | ECSP045153A (ru) |
MX (1) | MXPA04005003A (ru) |
NO (1) | NO20042612L (ru) |
WO (1) | WO2003045434A2 (ru) |
ZA (1) | ZA200403162B (ru) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070300258A1 (en) * | 2001-01-29 | 2007-12-27 | O'connor Daniel | Methods and systems for providing media assets over a network |
DK1395289T3 (da) * | 2001-06-07 | 2011-03-28 | Christine Dr Sang | Behandling af neuropatisk smerte med en N-methyl-D-aspartat- (NMDA-)receptorantagonist |
TWI232102B (en) * | 2001-07-17 | 2005-05-11 | Shionogi & Co | A pharmaceutical formulation for injection |
DE10141650C1 (de) * | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
ES2384208T3 (es) | 2001-11-01 | 2012-07-02 | Spectrum Pharmaceuticals, Inc. | Composiciones medicinales para el tratatamiento intravesical del cáncer de vejiga. |
US8563592B2 (en) | 2001-11-01 | 2013-10-22 | Spectrum Pharmaceuticals, Inc. | Bladder cancer treatment and methods |
US7351692B2 (en) * | 2002-06-19 | 2008-04-01 | The Board Of Trustees Of The University Of Illinois | Method and composition for potentiating the antipyretic action of a nonopioid analgesic |
GB0219660D0 (en) | 2002-08-23 | 2002-10-02 | Astrazeneca Ab | Therapeutic use |
US20040138121A1 (en) | 2002-10-24 | 2004-07-15 | Anil Gulati | Method and composition for preventing and treating solid tumors |
US20070032422A1 (en) | 2002-10-24 | 2007-02-08 | Spectrum Pharmaceuticals, Inc. | Methods, compositions and articles of manufacture for contributing to the treatment of cancers |
US8217010B2 (en) | 2002-10-24 | 2012-07-10 | The Board Of Trustees Of The University Of Illinois | Methods, compositions and articles of manufacture for contributing to the treatment of solid tumors |
US8026216B2 (en) | 2002-10-24 | 2011-09-27 | Spectrum Pharmaceuticals, Inc. | Methods and compositions for contributing to the treatment of cancers |
GB0403744D0 (en) | 2004-02-20 | 2004-03-24 | Astrazeneca Ab | Chemical process |
US20090221490A1 (en) * | 2005-09-09 | 2009-09-03 | Anil Gulati | Endothelin Receptors In Morphine Withdrawal |
CA2625210A1 (en) * | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
CN101534852B (zh) | 2006-08-31 | 2013-02-13 | 光谱医药公司 | 通过施用内皮素激动剂使得肿瘤细胞对放疗敏化 |
GB0624880D0 (en) * | 2006-12-14 | 2007-01-24 | Johnson Matthey Plc | Improved method for making analgesics |
WO2009015917A2 (en) * | 2007-05-14 | 2009-02-05 | F. Hoffmann-La Roche Ag | Dihydroquinone and dihydronaphthridine inhibitors of jnk |
US20090143426A1 (en) * | 2007-12-04 | 2009-06-04 | Ralph Anthony Stephani | Synthesis of 1,3,6-trisubstituted-2-carboxyquinol-4-ones as selective ET A antagonists and their use as medicaments |
PL2424529T3 (pl) * | 2009-04-30 | 2017-06-30 | Midwestern University | Nowe postępowania terapeutyczne z zastosowaniem centakwiny |
US9308235B2 (en) | 2012-05-09 | 2016-04-12 | Spectrum Pharmaceuticals, Inc. | Treatment of primary and metastatic carcinoma |
ES2825101T3 (es) | 2013-07-08 | 2021-05-14 | Univ Midwestern | Composiciones y métodos para el tratamiento de trastornos neuropsiquiátricos usando un agonista del receptor de la endotelina B |
CN112569238A (zh) * | 2019-09-30 | 2021-03-30 | 武汉大学 | 伊马替尼及其衍生物与镇痛药联合用药或复方制剂在治疗疼痛中的应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5612359A (en) * | 1994-08-26 | 1997-03-18 | Bristol-Myers Squibb Company | Substituted biphenyl isoxazole sulfonamides |
JPH08139146A (ja) | 1994-11-14 | 1996-05-31 | Shin Etsu Handotai Co Ltd | 半導体表面のライフタイム評価方法 |
MX9703988A (es) | 1994-12-12 | 1998-02-28 | Omeros Med Sys Inc | SOLUCIaN Y MÉTODO DE IRRIGACIaN PARA LA INHIBICIaN DEL DOLOR, LA INFLAMACIaN Y ES ESPASMO. |
US6673832B1 (en) * | 1998-05-04 | 2004-01-06 | Gudarz Davar | Methods for identifying compounds for treating pain |
CA2409927A1 (en) | 2000-05-31 | 2001-12-06 | Warner-Lambert Company | Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic |
AU2002241736A1 (en) * | 2000-12-21 | 2002-07-01 | Bristol-Myers Squibb Company | Method for preventing or treating pain by administering an endothelin antagonist |
US20030232787A1 (en) * | 2001-05-08 | 2003-12-18 | Dooley David James | Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic |
-
2002
- 2002-11-21 US US10/301,449 patent/US7973064B2/en not_active Expired - Fee Related
- 2002-11-22 CA CA002464768A patent/CA2464768C/en not_active Expired - Fee Related
- 2002-11-22 WO PCT/US2002/037461 patent/WO2003045434A2/en active Application Filing
- 2002-11-22 EP EP02782353A patent/EP1448233A2/en not_active Ceased
- 2002-11-22 JP JP2003546935A patent/JP2005513033A/ja active Pending
- 2002-11-22 CN CNA028235703A patent/CN1646166A/zh active Pending
- 2002-11-22 MX MXPA04005003A patent/MXPA04005003A/es not_active Application Discontinuation
- 2002-11-22 BR BR0214481-6A patent/BR0214481A/pt not_active IP Right Cessation
- 2002-11-22 AU AU2002348224A patent/AU2002348224A1/en not_active Abandoned
- 2002-11-22 EA EA200400734A patent/EA200400734A1/ru unknown
-
2004
- 2004-04-26 ZA ZA200403162A patent/ZA200403162B/en unknown
- 2004-06-08 CO CO04053708A patent/CO5590940A2/es not_active Application Discontinuation
- 2004-06-15 EC EC2004005153A patent/ECSP045153A/es unknown
- 2004-06-22 NO NO20042612A patent/NO20042612L/no not_active Application Discontinuation
-
2009
- 2009-11-03 US US12/611,307 patent/US8114896B2/en not_active Expired - Fee Related
-
2010
- 2010-08-02 US US12/848,378 patent/US8410148B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US7973064B2 (en) | 2011-07-05 |
EP1448233A2 (en) | 2004-08-25 |
CA2464768C (en) | 2009-12-29 |
CA2464768A1 (en) | 2003-06-05 |
MXPA04005003A (es) | 2004-08-11 |
US20100311665A1 (en) | 2010-12-09 |
US20030100507A1 (en) | 2003-05-29 |
ZA200403162B (en) | 2005-01-26 |
CO5590940A2 (es) | 2005-12-30 |
JP2005513033A (ja) | 2005-05-12 |
BR0214481A (pt) | 2004-09-14 |
NO20042612L (no) | 2004-06-22 |
WO2003045434A3 (en) | 2003-09-25 |
WO2003045434A2 (en) | 2003-06-05 |
US8114896B2 (en) | 2012-02-14 |
US20100113396A1 (en) | 2010-05-06 |
CN1646166A (zh) | 2005-07-27 |
AU2002348224A1 (en) | 2003-06-10 |
ECSP045153A (es) | 2004-08-27 |
US8410148B2 (en) | 2013-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200400734A1 (ru) | Способ и композиция для потенциирования действия опиатного анальгетика | |
MXPA05010819A (es) | Uso de antagonistas de opioide perifericos, especialmente metilnaltrexona para tratar sindrome de intestino irritable. | |
DE60327999D1 (de) | Azolylaminoazine als inhibitoren von proteinkinasen | |
ATE446751T1 (de) | Verwendung von methylnaltrexon zur behandlung von immunsuppression | |
DK1265630T3 (da) | Anvendelse af insulin til behandling af brusksygdomme | |
PE20020521A1 (es) | Compuestos heterociclicos sustituidos para tratar la resistencia a multiples drogas | |
ATE466580T1 (de) | Azolylaminoazine als proteinkinasehemmer | |
HK1069339A1 (en) | Substituted diketopiperazines as oxytocin antagonists | |
BR9814923A (pt) | Método para tratamento de doença de alzheimer | |
ATE344031T1 (de) | Thrombopoietin-mimetika | |
EA200401341A1 (ru) | Применение остеопротегерина для лечения и/или профилактики фиброзного заболевания | |
EA200200132A1 (ru) | СЕЛЕКТИВНЫЕ АНТАГОНИСТЫ РЕЦЕПТОРА iGluRДЛЯ ЛЕЧЕНИЯ МИГРЕНИ | |
ATE389651T1 (de) | Als inhibitoren von c-met geeignete pyrrolzusammensetzungen | |
ATE406159T1 (de) | Behandlung von hyperlipidämie | |
EA200500803A1 (ru) | Антагонисты ccr1 для лечения воспалительных артритов, демиелинизационных воспалительных заболеваний | |
ATE516027T1 (de) | Orazamid orotat zur vorbeugung von leberschäden | |
DE60140960D1 (de) | Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis | |
ATE369348T1 (de) | Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie | |
WO2004071413A3 (en) | Method and composition for potentiating an opiate analgesic | |
MXPA03011270A (es) | Uso de antagonistas rank para tratar cancer. | |
DK1051187T3 (da) | Behandling af follikulære lymfomer ved anvendelse af inhibitorer af lymfotoxin(LT)-syntesevejen | |
ATE335739T1 (de) | Cak inhibitoren und deren verwendungen | |
BR0111785A (pt) | Composições e métodos para tratamento de candidìase | |
DE60236927D1 (de) | Suchtpraevention in der schmerzbehandlung mit gamma vinyl gaba | |
SE0103795D0 (sv) | Compounds and method for the treatment of överactive bladder |